INTERROS: Press Center: news

News

Press Center

phone: +7 495 785 29 07
fax: +7 499 230 32 94
press@interros.ru

Contacts

Topics

Norilsk Nickel

Calendar

prev next January 2024

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Actual

10.02.2021

Vladimir Potanin Supports Leading Russian Scientists To Propel Fundamental Research of Human Brain in Russia

Vladimir Potanin donated 500 million rubles ($6.7ml) aimed for creation of smart materials with pre-programmed properties. The project envisages establishment of a brand new Laboratory of Programmable Functional Materials, and will be carried out under the leadership of the Nobel laureate Konstantin Novoselov. More Topics Vladimir Potanin / Interros / Konstantin Novoselov / Tagir Aushev / Human Brain / Fundamental research / physics

18.06.2021

Interros did not participate in the buyback of Norilsk Nickel shares

Interros has not applied for the buyback of its Norilsk Nickel shares. As a result of the buyback, Interros share in Norilsk Nickel will increase, which is in line with our long-term strategy.

More Topics Interros / Norilsk Nickel / buyback

22.07.2020

International Clinical Trial Of Polyoxidonium Confirms Its Safety For Covid-19 Treatment

A Russian original medication called Polyoxidonium® by Petrovax, a pharmaceutical company affiliated to the Interros Group, has passed the first phase of an international clinical trial for its effectiveness and safety for COVID-19 treatment.